Skip to main content

Table 1 Assessment of intratumoral inflammatory cells expressing immune related markers

From: Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

Immune markers

Patient 1

Patient 2

Patient 3

CD3

127a

106

185

CD8

98

83

170

Tbet

13

<  4

27

GZMB

<  4

<  4

12

CD68

137

80

257

CD163

104

115

153

PDL-1

11

<  4

<  4

PD-1

<  4

6

16

  1. aNumber/mm2 of immune tumor-infiltrating cells expressing the indicated markers. See Materials and Methods for details
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us